BIOLASE Balance Sheet Health
Financial Health criteria checks 0/6
BIOLASE has a total shareholder equity of $-3.3M and total debt of $16.0M, which brings its debt-to-equity ratio to -486.1%. Its total assets and total liabilities are $27.2M and $30.5M respectively.
Key information
-486.1%
Debt to equity ratio
US$16.04m
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.44m |
| Equity | -US$3.30m |
| Total liabilities | US$30.54m |
| Total assets | US$27.24m |
Recent financial health updates
Recent updates
Biolase partners with dental speciality programs across U.S.
Aug 31BIOLASE: Ongoing Operating Losses, Capital Raises To Sustain Liquidity
Jul 21BIOLASE amends senior secured term loan with SWK Funding
Jul 01BIOLASE: Bad News Across The Board - Sell
Mar 21Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?
Feb 24
BIOLASE - Speculative Buy After Strong Preliminary Q4 Results
Jan 11BIOLASE - Good News Across The Board But Still Only Suited For The Most Speculative Investors
Nov 24Financial Position Analysis
Short Term Liabilities: BIOL.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: BIOL.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: BIOL.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: BIOL.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIOL.Q has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: BIOL.Q has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.8% each year